SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-028742
Filing Date
2021-04-27
Accepted
2021-04-27 20:46:52
Documents
1
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 5458
  Complete submission text file 0001209191-21-028742.txt   6925
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O SANGAMO THERAPEUTICS, INC. 501 CANAL BLVD. RICHMOND CA 94804
Business Address
Duraibabu Prathyusha (Reporting) CIK: 0001779092 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-30171 | Film No.: 21861043